Portal de investigación
Azacitidine in older patients with acute myeloid leukemia (AML). Results from the ALMA study according to the MRC risk index score.
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Falantes, Jose F.
- Martinez Robles, Violeta
- Bargay, Joan
- Deben, Guillermo
- Garrido, Ana
- Casano, Javier
- Salamero, Olga
- Bergua, Juan M.
- Colado, Enrique
- Garcia, Regina
- Pedro, Carmen
- Redondo, Santiago
- Tormo, Mar
- Diez-Campelo, Maria
- Perez-Encinas, Manuel
- de la Fuente, Adolfo
- Xicoy, Blanca
- Ramos, Fernando
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Falantes,JF,Martinez,V,Bargay,J,Deben,G,Garrido,A,Casano,J,Salamero,O et al. Azacitidine in older patients with acute myeloid leukemia (AML). Results from the ALMA study according to the MRC risk index score. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer. 2015. Chicago. TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103:LIPPINCOTT WILLIAMS & WILKINS. 2015.